Calculate Value in Use for Impairment – Your Expert Guide

Determine the recoverable amount of your assets using the Value in Use method for impairment testing. Our calculator provides a clear, step-by-step analysis.

Value in Use for Impairment Calculator

Projected vs. Discounted Cash Flows

Detailed Cash Flow Analysis

A breakdown of projected cash flows, discount factors, and their present values for each period, contributing to the Value in Use for Impairment.

Year	Projected Cash Flow	Discount Factor	Present Value

What is Value in Use for Impairment?

Value in Use for Impairment is a critical concept in financial accounting, particularly under international accounting standards like IAS 36 (Impairment of Assets). It represents the present value of the future cash flows expected to be derived from an asset or a cash-generating unit (CGU). When an entity assesses whether an asset is impaired, it compares the asset’s carrying amount (its value on the balance sheet) with its recoverable amount. The recoverable amount is the higher of the asset’s fair value less costs of disposal and its Value in Use for Impairment.

The core idea behind Value in Use for Impairment is to determine the economic benefit an entity expects to gain from continuing to use an asset and eventually disposing of it. This involves forecasting future cash inflows and outflows associated with the asset and then discounting these future amounts back to their present value using an appropriate discount rate. If the carrying amount of an asset exceeds its recoverable amount (which includes its Value in Use for Impairment), the asset is considered impaired, and an impairment loss must be recognized.

Who Should Use Value in Use for Impairment?

• Accountants and Financial Professionals: Essential for preparing financial statements in compliance with IAS 36.
• Auditors: To verify the impairment assessments made by companies.
• Business Owners and Managers: To understand the true economic value of their assets and make informed capital allocation decisions.
• Investors and Analysts: To evaluate the financial health and asset quality of companies.
• Valuation Specialists: As a key methodology in asset valuation.

Common Misconceptions about Value in Use for Impairment

• It’s the same as Fair Value: While both involve valuation, fair value is a market-based measure (what a third party would pay), whereas Value in Use for Impairment is entity-specific (what the current owner expects to gain).
• It only considers cash inflows: Value in Use for Impairment considers both cash inflows and cash outflows necessary to generate those inflows, including maintenance, operating costs, and eventual disposal costs.
• It uses a post-tax discount rate: IAS 36 explicitly requires a pre-tax discount rate that reflects current market assessments of the time value of money and the risks specific to the asset.
• It’s a simple calculation: While the formula is straightforward, accurately forecasting future cash flows and determining an appropriate discount rate requires significant judgment and expertise.
• It’s only for tangible assets: Value in Use for Impairment applies to both tangible assets (e.g., property, plant, equipment) and intangible assets (e.g., patents, brands, goodwill).

Value in Use for Impairment Formula and Mathematical Explanation

The calculation of Value in Use for Impairment is fundamentally a discounted cash flow (DCF) exercise. It involves projecting future cash flows and discounting them back to their present value. The formula can be broken down into two main components: the present value of explicit forecast period cash flows and the present value of the terminal value.

Step-by-Step Derivation

1. Project Explicit Cash Flows: Estimate the net cash flows (inflows minus outflows) for each year of a detailed forecast period (typically 3-5 years). These cash flows should be pre-tax and exclude financing activities and income tax receipts/payments.
2. Calculate Discount Factor: For each period, determine the discount factor using the pre-tax discount rate. The discount factor for year ‘t’ is 1 / (1 + r)^t, where ‘r’ is the discount rate.
3. Calculate Present Value of Explicit Cash Flows: Multiply each projected cash flow by its corresponding discount factor. Sum these present values to get the total present value of explicit cash flows.
4. Calculate Terminal Value (TV): This represents the value of all cash flows beyond the explicit forecast period. It’s often calculated using the Gordon Growth Model (GGM) if a stable, perpetual growth rate is assumed. The formula for TV at the end of the last explicit forecast year (Year N) is:
   
   TV_N = CF_(N+1) / (r - g)
   
   Where CF_(N+1) is the cash flow in the first year beyond the explicit forecast period (i.e., Year N’s cash flow grown by the terminal growth rate), ‘r’ is the discount rate, and ‘g’ is the terminal growth rate. It is crucial that r > g.
5. Calculate Present Value of Terminal Value: Discount the Terminal Value (calculated at Year N) back to the present day.
   
   PV_TV = TV_N / (1 + r)^N
6. Sum for Total Value in Use: Add the sum of the present values of explicit cash flows and the present value of the terminal value.
   
   Value in Use = Sum(PV of Explicit Cash Flows) + PV of Terminal Value

Variable Explanations

Understanding each variable is key to accurately calculate Value in Use for Impairment.

Variable	Meaning	Unit	Typical Range
Number of Projection Periods (N)	The duration of the explicit forecast period in years.	Years	3-10 years (commonly 5)
Initial Annual Cash Flow (CF1)	The net cash flow expected in the first year of the projection.	Currency ($)	Varies widely by asset/CGU
Annual Cash Flow Growth Rate	The rate at which explicit cash flows are expected to increase or decrease annually.	Percentage (%)	-10% to +15%
Terminal Growth Rate (g)	The constant growth rate assumed for cash flows beyond the explicit forecast period.	Percentage (%)	0% to 3% (must be < discount rate)
Pre-Tax Discount Rate (r)	The rate used to discount future cash flows, reflecting the time value of money and asset-specific risks.	Percentage (%)	5% to 20%
Projected Cash Flow (CFt)	The estimated net cash flow for a specific period ‘t’.	Currency ($)	Varies
Discount Factor	The factor used to convert future cash flows to their present value.	Unitless	0 to 1
Present Value (PV)	The current value of a future sum of money or stream of cash flows.	Currency ($)	Varies

Practical Examples (Real-World Use Cases)

To illustrate how to calculate Value in Use for Impairment, let’s consider a couple of practical scenarios.

Example 1: Manufacturing Plant Impairment Test

A manufacturing company, “Industrial Gears Inc.”, owns a specialized plant with a carrying amount of $5,000,000. Due to a downturn in its specific market, the company suspects the plant might be impaired. They need to calculate its Value in Use for Impairment.

• Number of Projection Periods: 5 years
• Initial Annual Cash Flow (Year 1): $800,000
• Annual Cash Flow Growth Rate: 2%
• Terminal Growth Rate: 0.5%
• Pre-Tax Discount Rate: 9%

Calculation Steps:

1. Explicit Cash Flows:
   • Year 1: $800,000
   • Year 2: $800,000 * (1.02) = $816,000
   • Year 3: $816,000 * (1.02) = $832,320
   • Year 4: $832,320 * (1.02) = $848,966
   • Year 5: $848,966 * (1.02) = $865,945
2. Discounting Explicit Cash Flows:
   • PV Year 1: $800,000 / (1.09)^1 = $733,945
   • PV Year 2: $816,000 / (1.09)^2 = $686,000
   • PV Year 3: $832,320 / (1.09)^3 = $643,000
   • PV Year 4: $848,966 / (1.09)^4 = $604,000
   • PV Year 5: $865,945 / (1.09)^5 = $568,000

   Sum of Discounted Explicit Cash Flows = $733,945 + $686,000 + $643,000 + $604,000 + $568,000 = $3,234,945

3. Terminal Value (at end of Year 5):
   • CF Year 6 = $865,945 * (1.005) = $870,275
   • TV_5 = $870,275 / (0.09 – 0.005) = $870,275 / 0.085 = $10,238,529
4. Present Value of Terminal Value:
   • PV_TV = $10,238,529 / (1.09)^5 = $10,238,529 / 1.5386 = $6,654,500
5. Total Value in Use:
   • $3,234,945 (Explicit) + $6,654,500 (Terminal) = $9,889,445

Financial Interpretation: The Value in Use for Impairment is $9,889,445. Since this is higher than the carrying amount of $5,000,000, the asset is NOT impaired based on Value in Use alone. The company would then compare this to the fair value less costs of disposal to determine the final recoverable amount.

Example 2: Software License Impairment Test

A tech company, “Innovate Solutions”, holds a proprietary software license with a carrying amount of $2,000,000. Recent market shifts suggest its future revenue generation might be lower than initially expected.

• Number of Projection Periods: 4 years
• Initial Annual Cash Flow (Year 1): $600,000
• Annual Cash Flow Growth Rate: -1% (declining market)
• Terminal Growth Rate: 0% (no perpetual growth expected)
• Pre-Tax Discount Rate: 12%

Calculation Steps:

1. Explicit Cash Flows:
   • Year 1: $600,000
   • Year 2: $600,000 * (0.99) = $594,000
   • Year 3: $594,000 * (0.99) = $588,060
   • Year 4: $588,060 * (0.99) = $582,179
2. Discounting Explicit Cash Flows:
   • PV Year 1: $600,000 / (1.12)^1 = $535,714
   • PV Year 2: $594,000 / (1.12)^2 = $473,000
   • PV Year 3: $588,060 / (1.12)^3 = $418,900
   • PV Year 4: $582,179 / (1.12)^4 = $370,900

   Sum of Discounted Explicit Cash Flows = $535,714 + $473,000 + $418,900 + $370,900 = $1,798,514

3. Terminal Value (at end of Year 4):
   • CF Year 5 = $582,179 * (1.00) = $582,179
   • TV_4 = $582,179 / (0.12 – 0.00) = $582,179 / 0.12 = $4,851,492
4. Present Value of Terminal Value:
   • PV_TV = $4,851,492 / (1.12)^4 = $4,851,492 / 1.5735 = $3,083,200
5. Total Value in Use:
   • $1,798,514 (Explicit) + $3,083,200 (Terminal) = $4,881,714

Financial Interpretation: The Value in Use for Impairment is $4,881,714. This is significantly higher than the carrying amount of $2,000,000. Therefore, the software license is not impaired based on Value in Use. This example highlights that even with negative growth in explicit periods, a substantial terminal value can lead to a high Value in Use for Impairment.

How to Use This Value in Use for Impairment Calculator

Our Value in Use for Impairment calculator is designed to be intuitive and provide quick, accurate results for your impairment testing needs. Follow these steps to utilize it effectively:

Step-by-Step Instructions

1. Input Number of Projection Periods (Years): Enter the number of years for which you have detailed cash flow forecasts. This is typically 3 to 5 years.
2. Input Initial Annual Cash Flow ($): Provide the estimated net cash flow for the first year of your projection. Ensure this is a pre-tax figure.
3. Input Annual Cash Flow Growth Rate (%): Enter the expected annual growth rate for your explicit cash flows. This can be positive, negative, or zero.
4. Input Terminal Growth Rate (%): Specify the perpetual growth rate for cash flows beyond your explicit projection period. This rate should generally be low (e.g., 0-3%) and, critically, must be less than your Pre-Tax Discount Rate.
5. Input Pre-Tax Discount Rate (%): Enter the appropriate pre-tax discount rate that reflects the time value of money and the specific risks associated with the asset or cash-generating unit.
6. Click “Calculate Value in Use”: The calculator will automatically update results as you type, but you can click this button to ensure all calculations are refreshed.
7. Review Results: The “Total Value in Use” will be prominently displayed. You’ll also see intermediate values like “Sum of Discounted Explicit Cash Flows,” “Terminal Value (at end of projection),” and “Present Value of Terminal Value.”
8. Analyze Chart and Table: The “Projected vs. Discounted Cash Flows” chart visually represents your cash flow projections and their present values. The “Detailed Cash Flow Analysis” table provides a year-by-year breakdown.
9. Use “Reset” and “Copy Results”: The “Reset” button will clear all inputs and set them back to default values. The “Copy Results” button allows you to easily transfer the key outputs and assumptions to your reports or spreadsheets.

How to Read Results

• Total Value in Use: This is the primary output, representing the present value of all future cash flows expected from the asset. This is the figure you compare against the asset’s carrying amount (and fair value less costs of disposal) for impairment testing.
• Sum of Discounted Explicit Cash Flows: This shows the portion of Value in Use derived from your detailed, short-term forecasts.
• Terminal Value (at end of projection): This is the estimated value of the asset’s cash flows beyond the explicit forecast period, calculated at the end of the last explicit year.
• Present Value of Terminal Value: This is the discounted value of the terminal value, brought back to the present day. Often, this component represents a significant portion of the total Value in Use for Impairment.

Decision-Making Guidance

Once you have calculated the Value in Use for Impairment, you can use it as follows:

1. Determine Recoverable Amount: Compare the calculated Value in Use with the asset’s fair value less costs of disposal. The higher of these two figures is the asset’s recoverable amount.
2. Impairment Test: Compare the recoverable amount to the asset’s carrying amount (book value).
3. Recognize Impairment Loss: If the carrying amount exceeds the recoverable amount, the asset is impaired. An impairment loss must be recognized in the income statement, reducing the asset’s carrying amount to its recoverable amount.
4. Strategic Insights: The calculation process itself provides valuable insights into the drivers of an asset’s value, helping management understand which factors most significantly impact its future profitability and potential for impairment.

Key Factors That Affect Value in Use for Impairment Results

The accuracy and reliability of your Value in Use for Impairment calculation depend heavily on the assumptions made for several key factors. Understanding these factors is crucial for robust impairment testing and financial reporting.

• Future Cash Flow Projections: This is arguably the most critical factor. Overly optimistic or pessimistic forecasts of revenues, operating costs, capital expenditures, and working capital changes will directly inflate or deflate the Value in Use for Impairment. These projections must be realistic, supportable, and consistent with external market data and internal budgets.
• Pre-Tax Discount Rate: The discount rate reflects the time value of money and the specific risks associated with the asset or cash-generating unit. A higher discount rate will result in a lower Value in Use for Impairment, as future cash flows are discounted more heavily. Conversely, a lower rate increases Value in Use. Determining the appropriate pre-tax rate requires careful consideration of market interest rates, asset-specific risks, and the entity’s cost of capital.
• Terminal Growth Rate: This rate assumes a perpetual growth of cash flows beyond the explicit forecast period. Even a small change in this rate can significantly impact the terminal value, which often constitutes a large portion of the total Value in Use for Impairment. It should be a sustainable, long-term growth rate, typically not exceeding the long-term average growth rate of the economy in which the asset operates.
• Length of Projection Period: While IAS 36 generally suggests a maximum of five years for explicit forecasts, longer periods can be justified in certain circumstances. A longer explicit period can capture more detailed cash flow dynamics but also introduces greater uncertainty. The choice of period impacts how much of the value is captured in explicit forecasts versus the terminal value.
• Inflation Expectations: Inflation can impact both future cash flow projections (e.g., rising costs, potential for higher revenues) and the discount rate. Consistent treatment of inflation is essential: if cash flows are projected in nominal terms (including inflation), the discount rate must also be nominal. If cash flows are real (excluding inflation), the discount rate should be real.
• Asset-Specific Risks: Beyond general market risks, specific risks related to the asset (e.g., technological obsolescence, regulatory changes, competitive pressures, operational inefficiencies) must be factored into the cash flow projections or the discount rate. Higher specific risks generally lead to a higher discount rate or lower projected cash flows, thus reducing the Value in Use for Impairment.

Frequently Asked Questions (FAQ)

Q: What is the difference between Value in Use for Impairment and Fair Value Less Costs of Disposal?

A: Value in Use for Impairment is an entity-specific value, representing the present value of cash flows an entity expects to derive from an asset. Fair Value Less Costs of Disposal is a market-based value, representing the price that would be received to sell an asset in an orderly transaction between market participants, less the costs of selling.

Q: Why is a pre-tax discount rate used for Value in Use for Impairment?

A: IAS 36 requires a pre-tax discount rate to ensure consistency with the pre-tax nature of the cash flow projections. If post-tax cash flows were used, a post-tax discount rate would be appropriate, but the standard generally prefers pre-tax for Value in Use for Impairment.

Q: Can Value in Use for Impairment be negative?

A: Theoretically, if an asset is expected to generate significant net cash outflows over its remaining life, its Value in Use for Impairment could be negative. However, in practice, if an asset is expected to generate negative cash flows, it would likely be disposed of, and its recoverable amount would be its fair value less costs of disposal (which could be zero or negative if disposal costs exceed fair value).

Q: What happens if the terminal growth rate is equal to or greater than the discount rate?

A: If the terminal growth rate is equal to or greater than the discount rate, the Gordon Growth Model for terminal value calculation yields an infinite or undefined result. This indicates that the assumptions are unrealistic for a going concern and must be revisited. The terminal growth rate must always be strictly less than the discount rate.

Q: How often should Value in Use for Impairment be calculated?

A: An entity must assess at each reporting date whether there is any indication that an asset may be impaired. If such an indication exists, the entity must estimate the asset’s recoverable amount (including Value in Use for Impairment). For goodwill and intangible assets with indefinite useful lives, impairment testing is required at least annually.

Q: What types of cash flows should be included in the Value in Use for Impairment calculation?

A: Cash flows should include those directly attributable to the asset’s use and eventual disposal. This includes cash inflows from the asset’s operations and cash outflows for operating costs, maintenance, and necessary capital expenditures to maintain the asset’s current level of economic benefit. It excludes cash flows from financing activities and income tax receipts or payments.

Q: Can Value in Use for Impairment be used for a group of assets?

A: Yes, if an individual asset does not generate cash inflows that are largely independent of those from other assets, its Value in Use for Impairment is determined for the cash-generating unit (CGU) to which the asset belongs. A CGU is the smallest identifiable group of assets that generates cash inflows largely independent of the cash inflows from other assets or groups of assets.

Q: What if the asset has no future cash flows?

A: If an asset is expected to generate no future cash flows, its Value in Use for Impairment would be zero. In such a case, the recoverable amount would likely be determined by its fair value less costs of disposal, which could also be zero or negative if disposal costs are incurred.

Related Tools and Internal Resources

Explore our other financial tools and in-depth guides to enhance your understanding of asset valuation and financial analysis:

• Impairment Testing Guide: A comprehensive overview of the impairment process and accounting standards.
• Discounted Cash Flow (DCF) Calculator: Calculate the present value of future cash flows for various investment scenarios.
• Asset Valuation Principles: Learn about different methodologies and approaches to valuing assets.
• Fair Value Calculator: Determine the fair value of assets or liabilities based on market inputs.
• Accounting Standards Explained: Understand the nuances of IFRS and GAAP relevant to financial reporting.
• Recoverable Amount Analysis: Dive deeper into determining the recoverable amount for impairment assessments.